US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalD
DXR
DAXOR CORP
8.35
0.21+2.58%Closed16:00 12/20 EST
OPEN/PREV CLOSE8.04/8.14
TODAY RANGE8.04-8.35
VOL1.09K
MARKET CAP40.41M
52 WEEK RANGE7.16-10.04
AVG VOL (3M)16.64K
% TURNOVER0.02%
TURNOVER--
P/E (TTM)24.73
% RANGE4.55%
EPS(TTM)0.3376
P/E(FORWARD)4.639
P/B1.238
BVPS6.75
DIVIDEND--
P/S245.59
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP16.93M
SHARES OUTSTANDING4.84M
NEXT EARNINGS--
FREE FLOAT2.03M
LOT SIZE1
EX-DIV DATE01/05/2018
News
Press Releases
Financial Reports
Profile
TipRanks·4d ago
Daxor expands ezBVA Lab service to two new hospital systems
TipRanks·10/09 12:05
Daxor’s BVA-100 diagnostic featured at MedAxiom CV Transforum Fall ’24
TipRanks·09/27 21:10
Daxor to resubmit 510(k) application for blood volume analyzer platform
Reuters·09/27 21:00
DAXOR CORP - TO WITHDRAW DUAL 510(K)/CLIA-WAIVER APPLICATION
Reuters·09/27 21:00
DAXOR CORP - TO PURSUE SEPARATE CLIA-WAIVER APPLICATION
Dow Jones·09/09 10:06
Daxor Is Maintained at Buy by Ascendiant Capital
Dow Jones·09/09 10:06
Daxor Price Target Raised to $24.75/Share From $24.50 by Ascendiant Capital
Benzinga·09/09 09:57
Ascendiant Capital Maintains Buy on Daxor, Raises Price Target to $24.75
Reuters·08/06 12:00
DAXOR CORP - AWARDED $1.9M TWO-YEAR CONTRACT FROM USAF
Seeking Alpha·06/05 12:11
Daxor names John Jefferies as chief medical officer
Same Industry
Name/Symbol
Change%
Price